Stanford researchers have developed mutant Renilla luciferase proteins and reporter gene constructs which modify the physical characteristics of the Renilla luciferase protein for use in biological assays.
Researchers at Stanford have developed an in vivo drug release monitoring method using magnetic particle imaging (MPI). In vivo drug release monitoring is beneficial to doctors as it provides information to guide drug dosing and helps reduce therapeutic side effects.
Stanford researchers have developed a lanthanide-doped upconverting nanoparticle (UCNP) that emits very photostable and non-blinking light, and is bright enough to delineate tumor boundaries to the naked eye during surgery.
Researchers in Dr. Jianghong Rao's lab have developed nanoprobes for monitoring drug-induced hepatotoxicity in vivo in real time. Drug toxicity is a long-standing concern of modern medicine.
Stanford researchers at the Rao Lab have developed apoptosis imaging probes with an improved new molecular structure enabling high sensitivity and stability with better performance in vivo.
Researchers at Stanford have developed a dual modality imaging probe to provide improved atherosclerosis detection and evaluation. Atherosclerosis is a disease in which plaque builds up inside arteries.
Researchers at Stanford have developed a ferumoxytol-based dual-modality imaging probe that allows for long-term stem cell tracking through MRI and early diagnosis of cell apoptosis through simultaneous fluorescence imaging.
Dr. Sanjiv Gambhir and colleagues have developed positron emission tomography (PET) tracers to clinically image bacterial infection. Despite significant developments in the microbiology of infection, bacterial infections remain a major health issue.
A team of Stanford engineers have developed a fast adaptive optics system for scanning, 3D imaging and sensing with a small (50 µm) multimode fiber (MMF).